The Joint Corp. reiterated sales guidance for the year 2024. 2024 System-wide sales are expected to be between $530 million and $545 million, compared to $488.0 million in 2023.

System-wide comp sales for all clinics open 13 months or more are expected to be in the mid-single digits in 2024.